Pharmaceutical Policy
Documents
Citizen Petition from The Doctor Patient Forum
1,494 comments
Net support +41% across analyzed comments
Top issues in comments
- Patient access to pain medication
- Narxcare regulation
- Patient stigmatization and discrimination
Citizen Petition from Alliance to Protect Insulin Choice
41 comments
Net support +78% across analyzed comments
Top issues in comments
- Insulin availability and alternatives
- Basal insulin action profile
- Insulin use in pregnancy
Citizen Petition from Pharmaceutical Safety Oversight Council
6 comments
Net support +100% across analyzed comments
Top issues in comments
- Adverse drug reactions
Citizen Petition from Alliance for Pharmacy Compounding
3 comments
Net support +33% across analyzed comments
Top issues in comments
- Regulatory classification of dte
- Safety and efficacy of dte
Citizen Petition from Evan H. Couture
2 comments
Net support +100% across analyzed comments
Top issues in comments
- Regulatory consistency
- Regulatory parity and consistency
Medicare Program: Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program
0 comments
Analysis in progress
Top issues in comments
Certain Estrogen-Androgen Combination Drugs; Drugs for Human Use; Drug Efficacy Study Implementation; Amendment and Opportunity for Hearing
0 comments
Net support 0% across analyzed comments
Top issues in comments
- Medical necessity of estratest
- Availability of estrogen/androgen therapy
- Libido and sexual dysfunction
Reference List re: Certain Estrogen-Androgen Combination Drugs; Drugs for Human Use; Drug Efficacy Study Implementation; Amendment and Opportunity for Hearing
0 comments
Analysis in progress
Top issues in comments
Drugs for Human Use; Drug Efficacy Study Implementation: Estrogen-Androgen Fixed-Combination Drug Products; Syntest D.S. and Syntest H.S. Tablets; Withdrawal of Hearing Requests; Final Resolution of Drug Efficacy Study Implementation 7661
0 comments
Analysis in progress
Top issues in comments
Citizen Petition from Solvay Pharmaceuticals
0 comments
Analysis in progress
Top issues in comments
Acknowledgement Letter from FDA DMB to Solvay Pharmaceuticals
0 comments
Analysis in progress
Top issues in comments
Answer Letter from FDA CDER to University of Massachusetts Dept of Obstetrics and Gynecology
0 comments
Analysis in progress
Top issues in comments